Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:H02CA07
|
| gptkbp:CASNumber |
gptkb:84371-65-3
|
| gptkbp:chemicalFormula |
gptkb:C29H35NO2
|
| gptkbp:contraindication |
pregnancy
women with unexplained vaginal bleeding patients taking corticosteroids patients with adrenal insufficiency |
| gptkbp:drugClass |
antiglucocorticoid
steroidogenesis inhibitor |
| gptkbp:genericName |
gptkb:mifepristone
|
| https://www.w3.org/2000/01/rdf-schema#label |
Korlym
|
| gptkbp:indication |
hyperglycemia secondary to Cushing's syndrome
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Corcept_Therapeutics
|
| gptkbp:mechanismOfAction |
glucocorticoid receptor antagonist
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
fatigue headache endometrial thickening |
| gptkbp:synonym |
gptkb:RU-486
|
| gptkbp:usedFor |
gptkb:Cushing's_syndrome
|
| gptkbp:bfsParent |
gptkb:Corcept_Therapeutics
gptkb:Mifepristone |
| gptkbp:bfsLayer |
7
|